Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: STE stock price vs PACB: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at PACB's multiple
Needs PACB P/E.
Implied fair value · at STE's multiple
Needs EPS (TTM) is negative, STE P/E.
Live quote
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: STE FY 2026 (ended Mar 31, 2026) · PACB FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
STERIS plc · implied price per share
Bear
$101.93
Base
$119.92
Bull
$137.91
Pacific Biosciences of California, Inc. · implied price per share
Bear
-$2.76
Base
-$3.25
Bull
-$3.73
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.27x
167.73x
Net debt / EBITDA
Leverage against operating earnings
1.02x
-4.53x
Cash and equivalents
Liquid reserves on the balance sheet
$220.53M
$279.51M
Total debt
Interest-bearing obligations outstanding
$1.93B
$897.17M
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Johnson & Johnson
STE vs JNJ
BAXTER INTERNATIONAL INC
STE vs BAX
BECTON DICKINSON & CO
STE vs BDX
ZIMMER BIOMET HOLDINGS, INC.
STE vs ZBH
ILLUMINA, INC.
STE vs ILMN
THERMO FISHER SCIENTIFIC INC.
STE vs TMO
AGILENT TECHNOLOGIES, INC.
STE vs A
DANAHER CORP /DE/
STE vs DHR
REVVITY, INC.
STE vs RVTY
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
